|
IPEC India to organize webinar on “Lipid Excipients for Solubility & BA Enhancement” in Mumbai on June 29
|
|
Shardul Nautiyal, Mumbai
June 21 , 2021
|
|
|
The International Pharmaceutical Excipients Council (IPEC), India will be organizing a Webinar on “Lipid Excipients for Solubility and Bioavailability Enhancement” in Mumbai on June 29, 2021. The programme will be chaired by Dr Agnivesh Shrivastava, regional technical manager, South India and Nepal, Gattefosse India Pvt Ltd, Mumbai.
Gattefossé India Pvt. Limited is a decade run strategic supplier of excipients to cosmetics and pharmaceuticals companies in India. This affiliate of Gattefossé is responsible for sales, marketing and technical service support throughout the Indian subcontinent and sustains a profitable operation, strongly supported by a professional and a motivated team.
The company has a well-equipped application lab – technical centre of excellence in Mumbai to enhance customer support. The technical centre of excellence has been established to address formulation development needs for customer projects and in house global technical requirements. It is a FDA approved laboratory to facilitate the use of API’s in pharmaceutical formulations.
The talk will cover application of lipid excipients in solubility and bioavailability enhancement of poorly water soluble drugs i.e. BCS Class II and IV. It will also include the steps involved in development of lipid formulations and their evaluation techniques with relevant case studies.
Lipid excipients are able to solubilize hydrophobic drugs within the dosage form matrix. However, as with dietary lipids, these excipients can also be digested and dispersed in the gastro-intestinal (GI) tract.
Dr Agnivesh Shrivastava has published multiple research papers, book chapters and meeting abstracts related to formulation development and drug delivery.
He has a work experience of over 12 years and has technical expertise in formulation development of oral and topical dosage forms, solubility and bioavailability enhancement, sustained release drug delivery, Lipid based formulations, Topical and transdermal drug delivery, nanoparticulate drug delivery, pulmonary and targeted drug delivery systems.
The excipient market in India has huge growth opportunities due to the availability of low-cost raw materials, labour costs and quick adaptability of suppliers to new technology.
The global pharmaceutical excipients market is projected to reach US$ 9.7 billion by 2025 from US$ 6.9 billion in 2019 at a CAGR of 5.8 per cent. The Indian excipient market is growing at 10 to 12 percent as against the global growth rate of 5 to7 percent.
By functionality, the fillers and diluents segment has the largest share of the pharmaceutical excipients market. By formulation, the oral formulations segment accounts for the largest share of the market.
Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs and increasing uptake of bio-pharmaceuticals are driving the market for pharmaceutical excipients.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|